Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Identification of patient-derived glioblastoma stem cell (GSC) lines with the alternative lengthening of telomeres phenotype.

Farooqi A, Yang J, Sharin V, Ezhilarasan R, Danussi C, Alvarez C, Dharmaiah S, Irvin D, Huse J, Sulman EP.

Acta Neuropathol Commun. 2019 May 16;7(1):76. doi: 10.1186/s40478-019-0732-4. No abstract available.

2.

G-quadruplex DNA drives genomic instability and represents a targetable molecular abnormality in ATRX-deficient malignant glioma.

Wang Y, Yang J, Wild AT, Wu WH, Shah R, Danussi C, Riggins GJ, Kannan K, Sulman EP, Chan TA, Huse JT.

Nat Commun. 2019 Feb 26;10(1):943. doi: 10.1038/s41467-019-08905-8.

3.

Novel insights into the epigenetics of diffuse glioma.

Danussi C, Huse JT.

Mol Cell Oncol. 2018 Aug 24;5(5):e1472055. doi: 10.1080/23723556.2018.1472055. eCollection 2018.

4.

Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodeling.

Danussi C, Bose P, Parthasarathy PT, Silberman PC, Van Arnam JS, Vitucci M, Tang OY, Heguy A, Wang Y, Chan TA, Riggins GJ, Sulman EP, Lang F, Creighton CJ, Deneen B, Miller CR, Picketts DJ, Kannan K, Huse JT.

Nat Commun. 2018 Mar 13;9(1):1057. doi: 10.1038/s41467-018-03476-6.

5.

Local inhibition of elastase reduces EMILIN1 cleavage reactivating lymphatic vessel function in a mouse lymphoedema model.

Pivetta E, Wassermann B, Del Bel Belluz L, Danussi C, Modica TM, Maiorani O, Bosisio G, Boccardo F, Canzonieri V, Colombatti A, Spessotto P.

Clin Sci (Lond). 2016 Jul 1;130(14):1221-36. doi: 10.1042/CS20160064. Epub 2016 Feb 26.

6.

Neutrophil elastase-dependent cleavage compromises the tumor suppressor role of EMILIN1.

Pivetta E, Danussi C, Wassermann B, Modica TM, Del Bel Belluz L, Canzonieri V, Colombatti A, Spessotto P.

Matrix Biol. 2014 Feb;34:22-32. doi: 10.1016/j.matbio.2014.01.018. Epub 2014 Feb 7.

PMID:
24513040
7.

EMILIN1/α9β1 integrin interaction is crucial in lymphatic valve formation and maintenance.

Danussi C, Del Bel Belluz L, Pivetta E, Modica TM, Muro A, Wassermann B, Doliana R, Sabatelli P, Colombatti A, Spessotto P.

Mol Cell Biol. 2013 Nov;33(22):4381-94. doi: 10.1128/MCB.00872-13. Epub 2013 Sep 9.

8.

The integrated landscape of driver genomic alterations in glioblastoma.

Frattini V, Trifonov V, Chan JM, Castano A, Lia M, Abate F, Keir ST, Ji AX, Zoppoli P, Niola F, Danussi C, Dolgalev I, Porrati P, Pellegatta S, Heguy A, Gupta G, Pisapia DJ, Canoll P, Bruce JN, McLendon RE, Yan H, Aldape K, Finocchiaro G, Mikkelsen T, Privé GG, Bigner DD, Lasorella A, Rabadan R, Iavarone A.

Nat Genet. 2013 Oct;45(10):1141-9. doi: 10.1038/ng.2734. Epub 2013 Aug 5.

9.

RHPN2 drives mesenchymal transformation in malignant glioma by triggering RhoA activation.

Danussi C, Akavia UD, Niola F, Jovic A, Lasorella A, Pe'er D, Iavarone A.

Cancer Res. 2013 Aug 15;73(16):5140-50. doi: 10.1158/0008-5472.CAN-13-1168-T. Epub 2013 Jun 17.

10.

An EMILIN1-negative microenvironment promotes tumor cell proliferation and lymph node invasion.

Danussi C, Petrucco A, Wassermann B, Modica TM, Pivetta E, Del Bel Belluz L, Colombatti A, Spessotto P.

Cancer Prev Res (Phila). 2012 Sep;5(9):1131-43. doi: 10.1158/1940-6207.CAPR-12-0076-T. Epub 2012 Jul 24.

11.

EMILIN1-α4/α9 integrin interaction inhibits dermal fibroblast and keratinocyte proliferation.

Danussi C, Petrucco A, Wassermann B, Pivetta E, Modica TM, Del Bel Belluz L, Colombatti A, Spessotto P.

J Cell Biol. 2011 Oct 3;195(1):131-45. doi: 10.1083/jcb.201008013. Epub 2011 Sep 26.

12.

A newly generated functional antibody identifies Tn antigen as a novel determinant in the cancer cell-lymphatic endothelium interaction.

Danussi C, Coslovi A, Campa C, Mucignat MT, Spessotto P, Uggeri F, Paoletti S, Colombatti A.

Glycobiology. 2009 Oct;19(10):1056-67. doi: 10.1093/glycob/cwp085. Epub 2009 Jun 15.

13.

Emilin1 deficiency causes structural and functional defects of lymphatic vasculature.

Danussi C, Spessotto P, Petrucco A, Wassermann B, Sabatelli P, Montesi M, Doliana R, Bressan GM, Colombatti A.

Mol Cell Biol. 2008 Jun;28(12):4026-39. doi: 10.1128/MCB.02062-07. Epub 2008 Apr 14.

14.

Laminin-332 (Laminin-5) is the major motility ligand for B cell chronic lymphocytic leukemia.

Spessotto P, Zucchetto A, Degan M, Wasserman B, Danussi C, Bomben R, Perris R, Canzonieri V, Radillo O, Colombatti A, Gattei V.

Matrix Biol. 2007 Jul;26(6):473-84. Epub 2007 Apr 11.

PMID:
17482449
15.

EMILIN1 represents a major stromal element determining human trophoblast invasion of the uterine wall.

Spessotto P, Bulla R, Danussi C, Radillo O, Cervi M, Monami G, Bossi F, Tedesco F, Doliana R, Colombatti A.

J Cell Sci. 2006 Nov 1;119(Pt 21):4574-84.

Supplemental Content

Loading ...
Support Center